Response to induction therapy
| . | After first induction, n . | Eligible for salvage, n . | Received salvage, n . | Overall response, n (%) . |
|---|---|---|---|---|
| CR | 223 | na* | 0 | 236 (57%) |
| CRi | 12 | na* | 0 | 17 (4%) |
| AML-FS | 21 | na* | 0 | 22 (5%) |
| PR | 4 | 4 | 1 | 6 (1%) |
| RD | 116 | 67 | 53 | 95 (23%) |
| ID | 40 | na | na | 40 (10%) |
| . | After first induction, n . | Eligible for salvage, n . | Received salvage, n . | Overall response, n (%) . |
|---|---|---|---|---|
| CR | 223 | na* | 0 | 236 (57%) |
| CRi | 12 | na* | 0 | 17 (4%) |
| AML-FS | 21 | na* | 0 | 22 (5%) |
| PR | 4 | 4 | 1 | 6 (1%) |
| RD | 116 | 67 | 53 | 95 (23%) |
| ID | 40 | na | na | 40 (10%) |
CR indicates complete remission; CRi, CR with incomplete blood count recovery; AML-FS, morphologic AML-free state; PR, partial remission; RD, resistant disease; na, not applicable.
According to the protocol, salvage was offered to PR and RD patients only.